跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clavisar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Clavisar
Approved
STANDARD
Clavisar
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
05cacede4135ec1e
Company
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Type
Standard
Approval Details
Approval Id
05cacede4135ec1e
Drug Approval Philippines Name
Clavisar
Product Name
Clavisar
Registration Number
DRP-6801-01
Brand Name
Clavisar
Generic Name
Co-Amoxiclav
Dosage Form
Powder For Injection (Iv)
Dosage Strength
1g/200mg
Manufacturer
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Importer
Sahar Internatioal Trading, Inc.
Distributor
Geofman Pharmaceuticals Subic, Inc.
Company Detail Path
/organization/cspc-zhongnuo-pharmaceutical-shijiazhuang-co-ltd
Issuance Date
07 August 2018
Expiry Date
13 September 2028
Pharmacologic Category
Antibacterial (Penicillin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
05cacede4135ec1e
Type
Standard
Back to Philippines FDA Approvals